HLB Pharmaceutical Co. Ltd Asset Resilience Ratio

Latest as of September 2025: 11.61%

HLB Pharmaceutical Co. Ltd asset resilience ratio. HLB Pharmaceutical Co. Ltd (047920) has an Asset Resilience Ratio of 11.61% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See HLB Pharmaceutical Co. Ltd defensive interval ratio to measure how many days the company can operate on defensive assets alone.

Liquid Assets

₩19.49 Billion

≈ $13.21 Million USD Cash + Short-term Investments

Total Assets

₩167.93 Billion

≈ $113.80 Million USD All company assets

Resilience Assessment

Moderate

Financial Resilience Level

Asset Resilience Ratio of HLB Pharmaceutical Co. Ltd (2014–2024)

Asset resilience ratio of HLB Pharmaceutical Co. Ltd from 2014 to 2024. This chart shows how HLB Pharmaceutical Co. Ltd's Asset Resilience Ratio has changed over time. Read how much debt does HLB Pharmaceutical Co. Ltd carry for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down HLB Pharmaceutical Co. Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see HLB Pharmaceutical Co. Ltd (047920) total assets.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	₩0.00	0%
Short-term Investments	₩19.49 Billion	11.61%
Total Liquid Assets	₩19.49 Billion	11.61%

Asset Resilience Insights

Moderate Liquidity: HLB Pharmaceutical Co. Ltd has 11.61% of assets in liquid form.
While adequate for normal operations, this level may limit flexibility during economic stress.
The company has significant short-term investments, indicating active treasury management.

HLB Pharmaceutical Co. Ltd Industry Peers by Asset Resilience Ratio

Compare HLB Pharmaceutical Co. Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Jiangsu Hengrui Medicine Co Ltd SHG:600276	Drug Manufacturers - Specialty & Generic	0.16%
Sandoz Group AG SW:SDZ	Drug Manufacturers - Specialty & Generic	7.89%
H Lundbeck A/S CO:HLUN-B	Drug Manufacturers - Specialty & Generic	-0.56%
Changchun High & New Technology Industries Group Inc SHE:000661	Drug Manufacturers - Specialty & Generic	5.50%
Hubei Jumpcan Pharmaceutical Co Ltd SHG:600566	Drug Manufacturers - Specialty & Generic	47.16%
Kangmei Pharmaceutical Co Ltd SHG:600518	Drug Manufacturers - Specialty & Generic	0.00%
Viyash Scientific Limited NSE:SEQUENT	Drug Manufacturers - Specialty & Generic	0.08%
Anhui Fengyuan Pharmaceutical Co Ltd SHE:000153	Drug Manufacturers - Specialty & Generic	1.81%

HLB Pharmaceutical Co. Ltd Asset Resilience Ratio by Year (2014–2024)

HLB Pharmaceutical Co. Ltd asset resilience ratio by year from 2014 to 2024. The table below shows the annual Asset Resilience Ratio data for HLB Pharmaceutical Co. Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	13.92%	₩21.99 Billion ≈ $14.90 Million	₩157.93 Billion ≈ $107.03 Million	-4.38pp
2023-12-31	18.30%	₩25.87 Billion ≈ $17.53 Million	₩141.35 Billion ≈ $95.79 Million	+0.99pp
2022-12-31	17.32%	₩24.62 Billion ≈ $16.69 Million	₩142.18 Billion ≈ $96.35 Million	-2.69pp
2021-12-31	20.01%	₩25.54 Billion ≈ $17.31 Million	₩127.63 Billion ≈ $86.49 Million	-51.12pp
2020-12-31	71.13%	₩79.25 Billion ≈ $53.71 Million	₩111.42 Billion ≈ $75.51 Million	+40.87pp
2019-12-31	30.25%	₩14.04 Billion ≈ $9.51 Million	₩46.39 Billion ≈ $31.44 Million	+21.30pp
2018-12-31	8.95%	₩3.26 Billion ≈ $2.21 Million	₩36.42 Billion ≈ $24.68 Million	-5.79pp
2017-12-31	14.74%	₩5.87 Billion ≈ $3.98 Million	₩39.85 Billion ≈ $27.00 Million	-14.17pp
2016-12-31	28.91%	₩11.92 Billion ≈ $8.08 Million	₩41.24 Billion ≈ $27.95 Million	+27.30pp
2015-12-31	1.61%	₩399.39 Million ≈ $270.66K	₩24.85 Billion ≈ $16.84 Million	-8.95pp
2014-12-31	10.56%	₩2.26 Billion ≈ $1.53 Million	₩21.43 Billion ≈ $14.53 Million	--

pp = percentage points

About HLB Pharmaceutical Co. Ltd

KQ:047920 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$191.38 Million

₩282.40 Billion KRW

Market Cap Rank

#16524 Global

#609 in Korea

Share Price

₩8610.00

Change (1 day)

-18.23%

52-Week Range

₩6170.00 - ₩20900.00

All Time High

₩41100.00